Visitboost: a home visiting enhancement to reduce harm for families affected by substance misuse

Active Grant Awarded

Award ID
R44DA057785
Recipient
Awarding agency
Obligated
$796,801

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 9% complete
Place of performance
Springfield, OR 97477, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse awarded Oregon Research Behavioral Intervention Strategies, Inc., doing business as Influents Innovations, $796,801 in obligated funds under Grant R44DA057785 on August 10, 2026. The award falls under the Drug Use and Addiction Research Programs (CFDA 93.279).

The grant funds the Phase II project of VisitBoost, a training and implementation support program intended to reduce stigma and strengthen knowledge and confidence among home visitors working with families affected by substance misuse. Phase I (R43DA057785) demonstrated feasibility, reduced stigma, increased knowledge and confidence, and received high ratings for acceptability, appropriateness, and feasibility. Aim 1 completes VisitBoost content and implementation enhancements, adding policy auditing, centralized technical assistance, communities of practice, and client involvement and feedback. Aim 2 assesses effectiveness against standard training in a cluster-randomized trial of 44 regions (440 home visitors). Aim 3 evaluates parent outcomes, measured as treatment utilization and recovery capital.

Ultimate completion is August 31, 2029, and place of performance is Springfield, OR 97477, USA.

Description

Abstract
Substance misuse during the peripartum period contributes to significant challenges for parents and children including barriers to accessing needed health and social services. More than 20,000 home visitors across the united states are positioned to provide frontline support during this critical window, stigma, lack of knowledge, however, organizational limitations often prevent them from effectively engaging parents with substance misuse. Home visitors themselves report a strong desire for additional training, particularly around emerging practices such as overdose prevention and non-punitive approaches to care. Without sustained supports, however, traditional one-time trainings have little lasting impact on workforce attitudes, practices, or organizational culture. Visitboost is an innovative training and implementation support program designed to reduce stigmatizing beliefs, strengthen home visitor knowledge and confidence, and promote organizational change. Visitboost focuses on improving evidence-based practices for building and maintaining relationships, connecting families to effective treatment and recovery services, and supporting safe caregiving and child development. Phase I (R43DA057785) demonstrated feasibility and proof of concept, with evidence of reduced stigma, increased knowledge and confidence, and high ratings of acceptability, appropriateness, and feasibility. The proposed phase II project has four aims: aim 1 will complete visitboost content and implementation enhancements, adding organizational strategies such as policy auditing, centralized technical assistance, communities of practice, and client involvement and feedback. Aim 2 will assess effectiveness compared to standard training in a cluster- randomized trial of 44 regions (440 home visitors). Aim 3 will evaluate parent outcomes (treatment utilization and recovery capital) in a subset of 240 parents with substance misuse (during pregnancy and the first year postpartum). Aim 4 will assess implementation outcomes, including cost, cost-effectiveness, penetration, and fidelity. By combining training, organizational strategies, and rigorous evaluation, visitboost has the potential to strengthen the home visiting workforce, increase family engagement in treatment and recovery supports, and improve outcomes for parents and infants during the peripartum period.

Quick answers

Who received award R44DA057785?

R44DA057785 was awarded to Oregon Research Behavioral Intervention Strategies, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 10, 2026.

How much is award R44DA057785 worth?

$796,801 has been obligated on R44DA057785.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award